Molecular mechanisms of cancer progression

University of Liverpool researchers work with colleagues around the world to understand the mechanisms that underpin cancer development and progression that can be used as a target for drugs and therapies. At the University of Liverpool researchers do research with translational potential focusing on patient need and collaborating clinical centres that could benefit millions of people.

Sharing pathways to tackle cancer’s major mutations

Sharing pathways to tackle cancer’s major mutations

Furthering our understanding of cancers and their connection to the Ras family of genes and their mutations.

Taking on cancer’s master controller

Taking on cancer’s master controller

Targeting common mechanisms in cancer research to look for targets for drugs and therapies.

News Story: LCRI and the Liverpool Head and Neck Centre Research Funding Successes

Two research projects led by Dr Jason Parsons have been granted funding totalling ~£2.2M from the NIH (National Institutes of Health) and the MRC (Medical Research Council). The first of the projects is ‘Realizing the radiobiological impact of protons and high-LET particles in head and neck cancer and glioblastoma models’ and the second being ‘Novel insights into the cellular response to complex DNA damage induced by proton beam therapy’. Click here to read the full news story.